Kathleen Sebelius, Director at Myovant Sciences Ltd. (MYOV), bought 5,000 shares at $8.95 ($45K) on 2019-06-12, disclosed to the SEC on 2019-06-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.92 | 300 | $3K | 6.0% |
| 2 | $8.93 | 100 | $893 | 2.0% |
| 3 | $8.95 | 100 | $895 | 2.0% |
| 4 | $8.96 | 4,500 | $40K | 90.0% |
| Total | $8.96 avg | 5,000 | $45K | 100% |
| Filing → |
| HUMA | SELL | 2024-09-11 | $28K | — | Filing → |